Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems
The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.
Eliaz Therapeutics is Raising Capital
The XGAL3® therapeutic apheresis device is the early-mover for the treatment of AKI. ETI has demonstrated significant survival benefits in preclinical models and their prototype device has successfully removed GAL-3 from human blood plasma.
Medidata Rave Imaging Reaches Milestone, Supporting More Than 1,000 Clinical Studies
Rave Imaging, built on the Medidata Unified Platform, processes more than 100 million images annually.
Q’Apel Medical, Inc. Awarded U.S. Patent for Its Highly Innovative SelectFlex™ Technology
The SelectFlex™ variable stiffness technology provides unparalleled tracking and support in neurovascular access cases.
Veranex Announces Acquisition of IMMR
IMMR, a leading preclinical science organization that provides preclinical research, pathology evaluation and surgical training services to medical technology innovators.